The Rubik’s Cube that is Big Pharma: Balancing Breakthrough Interventions & Billion Dollar Profits
With Erich Anderer, Mark Horowitz Mark Hyman Calley Means and Steve Andrzejewski

Big Pharma is a term for the world’s largest publicly traded pharmaceutical companies. It’s one of the most powerful industries in the world, and in 2024 has a projected global revenue north of $1,100 billion. As Americans, it’s particularly prescient for us, given that the U.S. generates nearly half of that revenue alone. When it comes to the drugs themselves, oncology drugs are expected to be the largest market this year, with a projected volume of $194 billion. Is it possible to imagine a world where these companies are relentlessly focused on maximizing human health, and the profits follow from that mission? That’s what we want to find out. In this dialogue, medical experts & healthcare industry leaders will come together to discuss the most impactful (and surprising) pharmaceutical interventions available now and in the near future, and to discuss the path towards a more equitable and ethical industry vision. Whether you’re a skeptic, an optimist, or just plain curious, join us, and expect to have your biases challenged and your perspective expanded.

Erich Anderer
Erich Anderer
Mark Horowitz
Mark Horowitz
Mark Hyman
Mark Hyman
Calley Means
Calley Means
Steve Andrzejewski
Steve Andrzejewski
Saturday, November 2, 3:30 PM - 4:30 PM
Ballroom ABC [Convention Center]